当前位置:主页 > 医学论文 > 药学论文 >

采用光谱法研究几种抗肿瘤药物与蛋白质的相互作用

发布时间:2018-06-29 10:35

  本文选题:光谱分析法 + 化学计量学方法 ; 参考:《西华师范大学》2015年硕士论文


【摘要】:青蒿素、双氢青蒿素、斑螫素、去甲斑螫素、新橙皮苷和柚皮苷等化合物均具备生物活性和药理功效。青蒿素和双氢青蒿素具有出色的抗疟活性,成为最重要的抗疟药物,此外它们还具有抗肿瘤、抗癌等作用;斑螫素和去甲斑螫素作为抗肿瘤药物用于治疗食道癌、肝癌、胃癌等,并且在许多细胞系中去甲斑螫素的毒素比斑螫素的少,所以它能够提供更多的临床应用;新橙皮苷具备抗增值、抗过敏、抗氧化、抗雌激素、抗肿瘤、清除自由基的活性和对胃病的保护作用等药理效应,而柚皮苷具有抗氧化、抗高胆固醇、抗炎、降血糖、抗凋亡及心脏保护等多种功效,成为新型的具有应用价值的药物。本文主要探讨这些具有抗肿瘤、抗癌等作用的药物与蛋白质间的相互作用,这些研究有助于理解该类药物在体内的运输、药理学作用信息、代谢动力学及为合成高活性该类药物类似物提供前期理论基础研究。具体研究内容如下:在模拟生理条件下,通过荧光、UV-vis吸收和红外光谱分别探究BSA与双氢青蒿素(DHA)和青蒿素(ART)相互作用。通过荧光发射和瑞利散射光谱分析DHA/ART与BSA的结合特性。由分析结果可知,BSA与DHA/ART间的猝灭机理属于静态猝灭。在四个不同温度下,分别计算DHA/ART-BSA体系的结合常数和绑定位点数。依据非辐射能量转移理论,计算获得BSA与DHA/ART间的绑定距离为1.54/1.65 nm。使用UV-vis吸收、同步荧光和三维荧光光谱讨论这两种药物对BSA结构的影响。此外,在DHA/ART存在下,运用红外光谱实验分析BSA特征吸收峰的峰位和强度变化,而且还采用模拟方法计算它们对应的红外光谱数据,得到BSA二级结构含量发生变化,即它们使该蛋白质的α-螺旋含量明显降低、β-片层和无规卷曲含量增加。最后,讨论共存离子对DHA/ART-BSA体系结合常数的影响。采用上述相同的方法分别研究斑蝥素/去甲斑蝥素(CTD/NCTD)与两种蛋白质(BSA和BHb)间的相互作用。研究结果表明这两种蛋白质分子上的色氨酸残基(Trp)微环境发生改变、较少的肽链展开和它们的疏水性随这两种药物浓度增大而增加。使用多元曲线分辨-交替最小二乘(MCR-ALS)方法进一步研究这四个绑定体系不同组份的浓度分布和对应的纯光谱。结果表明,游离的CTD/NCTD和BSA/BHb的拟合光谱与它们对应的实验测定光谱能很好地相吻合。根据MCRALS模型分析这四个绑定体系对应的荧光和UV-vis扩展数据矩阵的拟合结果,发现CTD/NCTD与这两种蛋白质结合形成四个复合物(如:CTD-BSA,NCTDBSA,CTD-BHb和NCTD-BHb)。此外,荧光猝灭结果表明,这两种蛋白质与CTD/NCTD的荧光猝灭均是静态猝灭机理。分别估算BSA-CTD/NCTD和BHbCTD/NCTD复合物的结合常数Kb、绑定位点数n、绑定距离r和热力学参数。红外光谱、同步荧光和三维荧光光谱的分析结果表明这两种药物能导致BSA/BHb的构象变化。运用几种不同光谱方法研究新橙皮苷/柚皮苷(NHD/NRG)与两种蛋白质(BSA和BHb)的相互作用。结果表明,这两种蛋白质与NHD/NRG间的猝灭机理为静态猝灭。在不同温度下,计算BSA/BHb-NHD/NRG体系对应的结合常数Kb和绑定位点数n、热力学参数和绑定距离r。采用三种不同方法分别讨论在NHD/NRG溶液中BSA/BHb构象的改变。探讨共存离子对BSA-NHD/NRG和BHbNHD/NRG体系结合常数的影响。此外,建立偏最小二乘(PLS)法同时测定胃复春片中NHD和NRG的新方法。
[Abstract]:Artemisinin, dihydroartemisinin, spot stingin, DMC, neohesperidin and naringin all have bioactivity and pharmacological effects. Artemisinin and dihydroarteminin have excellent antimalarial activity and become the most important antimalarial drugs. In addition, they have antitumor and anticancer effects; spot stingin and DMC are used as anti swelling agents. Tumor drugs are used to treat cancer of the esophagus, liver cancer, gastric cancer and so on, and in many cell lines, the toxin is less than the spot stingin, so it can provide more clinical applications; neohesperidin has the pharmacological effects of anti value added, anti allergy, antioxidation, anti estrogen, antitumor, activity of removing free radical and protective effect on stomach disease. Naringin has many functions, such as antioxidation, anti cholesterol, anti-inflammatory, hypoglycemic, anti apoptosis and heart protection and so on. It has become a new type of drug with application value. This paper mainly discusses the interaction between drugs and proteins, which have antitumor and anticancer effects. These studies help to understand the transport of such drugs in the body. Pharmacological action information, metabolic kinetics and a preliminary theoretical basis for the synthesis of high activity analogues. The specific contents are as follows: under simulated physiological conditions, the interaction between BSA and dihydroartemisinin (DHA) and artemisinin (ART) is investigated by fluorescence, UV-vis absorption and infrared spectroscopy. By fluorescence emission and Rayleigh dispersion According to the analysis results, the quenching mechanism between BSA and DHA/ART belongs to static quenching. At four different temperatures, the binding constant and the number of binding sites are calculated at four different temperatures. The binding distance between BSA and DHA/ART is 1.54/1.65 nm. based on the theory of non radiation energy transfer. The effects of these two drugs on the structure of BSA were discussed using UV-vis absorption, synchronous fluorescence and three-dimensional fluorescence spectroscopy. In addition, in the presence of DHA/ART, the peaks and intensity changes of the BSA characteristic absorption peaks were analyzed by infrared spectroscopy, and the corresponding red external spectral data were calculated by the simulation method, and the structure content of the BSA two structure was changed. They decrease the alpha helix content of the protein, increase the content of the beta lamellar and random curls. Finally, the effects of coexisting ions on the binding constant of the DHA/ART-BSA system are discussed. The interaction between cantharidin / norcantharidin (CTD/NCTD) and two proteins (BSA and BHb) is studied by the same method. It is shown that the microenvironment of tryptophan residues (Trp) on these two proteins changes, less peptide chain expansion and their hydrophobicity increase with the increase of the concentration of these two drugs. The concentration distribution and corresponding pure light of different components of the four binding systems are further studied by using the multivariate curve resolution alternating least squares (MCR-ALS) method. The results show that the fitting spectra of free CTD/NCTD and BSA/BHb are in good agreement with their corresponding experimental determination spectra. According to the analysis of the fitting results of the corresponding fluorescence and UV-vis extended data matrix of the four binding systems based on the MCRALS model, it is found that CTD/NCTD is combined with these two kinds of egg white matter to form four complexes (such as CTD-BSA, NCTD). BSA, CTD-BHb and NCTD-BHb). In addition, the fluorescence quenching results show that the fluorescence quenching of these two proteins and CTD/NCTD are both static quenching mechanisms. The binding constant Kb of BSA-CTD/NCTD and BHbCTD/NCTD complexes, binding distance n, binding distance r and thermodynamic parameters, red external spectra, synchronous fluorescence and three-dimensional fluorescence spectra are analyzed. The results showed that these two drugs could lead to the conformation changes of BSA/BHb. Several different spectral methods were used to study the interaction between new hesperidin / naringin (NHD/NRG) and two proteins (BSA and BHb). The results showed that the quenching mechanism between the two proteins and NHD/NRG was static quenching. At different temperatures, the corresponding BSA/BHb-NHD/NRG system was calculated. Combining constant Kb and binding location point n, thermodynamic parameters and binding distance R. are used to discuss the changes of BSA/BHb conformation in NHD/NRG solution respectively. The influence of coexistent ions on the binding constants of BSA-NHD/NRG and BHbNHD/NRG systems is discussed. In addition, a new method for simultaneous determination of NHD and NRG in gastric spring spring tablets by partial least squares (PLS) method is established. Law.
【学位授予单位】:西华师范大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R96;O657.3

【相似文献】

相关期刊论文 前10条

1 王征;董平原;张天民;林秀坤;;海洋抗肿瘤药物研究开发中的主要问题[J];食品与药品;2006年04期

2 周笑颜;彭文青;;抗肿瘤药物市场现状分析及其启示[J];医学信息;2007年09期

3 王壮志;谢敬东;傅强;;我国抗肿瘤药物市场存在的问题及对策探讨[J];中国医药导报;2009年05期

4 陆晓晶;;化学类抗肿瘤药物的研究进展[J];浙江化工;2010年07期

5 陈海燕;马爱霞;陈在余;;我国抗肿瘤药物市场现状及发展趋势研究[J];北方药学;2012年11期

6 程玲妹,,徐若璞,黄华惠,熊成东,邓先模;可生物降解长效缓释抗肿瘤药物的研究[J];合成化学;1994年01期

7 王允亭,王宁,王安民;世界最畅销的抗肿瘤药物[J];山东医药工业;1997年06期

8 ;抗肿瘤药物的发展趋势[J];化工文摘;2002年02期

9 普绍平,高文桂,余尧,刘祝东,刘伟平,杨一昆;新型铂族金属抗肿瘤药物赛特铂的研究现状[J];贵金属;2002年04期

10 蔡仲曦,干荣富;抗肿瘤药物市场分析[J];世界临床药物;2004年05期

相关会议论文 前10条

1 甄永苏;;分子靶向与综合调节:抗肿瘤药物研发的策略探讨[A];2010年中国药学大会暨第十届中国药师周报告集[C];2010年

2 李瑞珍;;护士接触抗肿瘤药物的危害及防护[A];全国肿瘤护理学术交流暨专题讲座会议论文汇编[C];2006年

3 沈雪琴;林能明;方罗;;抗肿瘤药物集中配制与职业防护分析[A];肿瘤化学治疗新进展学习班资料汇编[C];2007年

4 陈晓光;;抗肿瘤药物研究进展[A];第四届中国新医药博士论坛论文集[C];1999年

5 孙静;韩文志;柳燕;;抗肿瘤药物的不良反应及防治措施[A];2010施慧达杯第十届全国青年药学工作者最新科研成果交流会论文集[C];2010年

6 甄永苏;;分子靶向与综合调节:抗肿瘤药物研发的策略探讨[A];2010年中国药学大会暨第十届中国药师周论文集[C];2010年

7 陈晓光;;抗肿瘤药物研究新进展[A];全国第十二届生化与分子药理学学术会议论文集[C];2011年

8 胥彬;;抗肿瘤药物药理研究的新进展[A];中国药理学会第八次全国代表大会暨全国药理学术会议论文摘要汇编[C];2002年

9 林秀坤;;斑马鱼作为抗肿瘤药物模型的分子基础[A];第四届中国肿瘤学术大会暨第五届海峡两岸肿瘤学术会议论文集[C];2006年

10 丁健;;分子靶向抗肿瘤药物与生物标志物[A];2011年中国药学大会暨第11届中国药师周论文集[C];2011年

相关重要报纸文章 前10条

1 ;抗肿瘤药物市场将不断扩大[N];中国高新技术产业导报;2003年

2 ;我国抗肿瘤药物市场将不断扩大[N];中国中医药报;2003年

3 本报记者 欧慧敏;抗肿瘤药物研发觅径[N];医药经济报;2012年

4 本报记者 戴小河 实习生 曾烨轩;抗肿瘤药物市场增长迅速[N];中国证券报;2014年

5 严朝贵;抗肿瘤药物市场潜力惊人[N];中药报;2001年

6 殷妤涵;勃林格殷格翰加大抗肿瘤药物研发力度[N];中国医药报;2006年

7 本报记者 马飞;抗肿瘤药物研发:细胞模型成重中之重[N];医药经济报;2009年

8 本报记者 王朝选;市场潜力巨大 抗肿瘤药物研发待破局[N];中国高新技术产业导报;2009年

9 王朝选;机不可失 我国抗肿瘤药物研发待破局[N];中国医药报;2009年

10 本报特约撰稿人 樊平;新秀单抗进入蜜月期[N];医药经济报;2009年

相关博士学位论文 前6条

1 郦剑勇;苯并噻唑抗肿瘤药物的合成、筛选及其作用机理[D];浙江大学;2010年

2 谢红娟;利用上海市药物监测系统进行抗肿瘤药物的区级流行病学研究[D];上海交通大学;2007年

3 周宇;靶向性抗肿瘤药物EGF-E4orf4的研究[D];中国协和医科大学;2008年

4 陈淑珍;HERG-相关的抗肿瘤药物的敏感性及力达霉素药代动力学的研究[D];中国协和医科大学;2004年

5 陈光;雷帕霉素类抗肿瘤药物疗效预测的候选生物标记物研究[D];沈阳药科大学;2010年

6 张俊平;细胞毒抗肿瘤药物的共同基因表达谱的研究[D];第二军医大学;2007年



本文编号:2081832

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2081832.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户1c486***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com